These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22934617)

  • 1. Retroviral protein transfer: falling apart to make an impact.
    Maetzig T; Baum C; Schambach A
    Curr Gene Ther; 2012 Oct; 12(5):389-409. PubMed ID: 22934617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semliki Forest virus-mediated production of retroviral vector RNA in retroviral packaging cells.
    Wahlfors JJ; Xanthopoulos KG; Morgan RA
    Hum Gene Ther; 1997 Nov; 8(17):2031-41. PubMed ID: 9414252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the retrovirus transduction system.
    Cepko C; Pear W
    Curr Protoc Mol Biol; 2001 May; Chapter 9():Unit9.9. PubMed ID: 18265289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of a heterologous retroviral transport element in the development of genetic complementation assay for mouse mammary tumor virus (MMTV) replication.
    Rizvi TA; Ali J; Phillip PS; Ghazawi A; Jayanth P; Mustafa F
    Virology; 2009 Mar; 385(2):464-72. PubMed ID: 19157480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poxviral/retroviral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles.
    Holzer GW; Mayrhofer JA; Gritschenberger W; Dorner F; Falkner FG
    Virology; 1999 Jan; 253(1):107-14. PubMed ID: 9887323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable expression of the ecotropic retrovirus receptor in amphotropic packaging cells facilitates the transfer of recombinant vectors and enhances the yield of retroviral particles.
    Gerstmayer B; Groner B; Wels W; Schnierle BS
    J Virol Methods; 1999 Aug; 81(1-2):71-5. PubMed ID: 10488763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of untranslated regions on retroviral mRNA transfer and expression.
    Prel A; Sensébé L; Pagès JC
    BMC Biotechnol; 2013 Apr; 13():35. PubMed ID: 23586982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudotyped Viruses for Retroviruses.
    Solomon M; Liang C
    Adv Exp Med Biol; 2023; 1407():61-84. PubMed ID: 36920692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disclosing the Parameters Leading to High Productivity of Retroviral Producer Cells Lines: Evaluating Random Versus Targeted Integration.
    Bandeira VS; Tomás HA; Alici E; Carrondo MJ; Coroadinha AS
    Hum Gene Ther Methods; 2017 Apr; 28(2):78-90. PubMed ID: 28301970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress with retroviral gene vectors.
    Palù G; Parolin C; Takeuchi Y; Pizzato M
    Rev Med Virol; 2000; 10(3):185-202. PubMed ID: 10815029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccinia viral/retroviral chimeric vectors.
    Falkner FG; Holzer GW
    Curr Gene Ther; 2004 Dec; 4(4):417-26. PubMed ID: 15578991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral and non-viral approaches for transient delivery of mRNA and proteins.
    Schott JW; Galla M; Godinho T; Baum C; Schambach A
    Curr Gene Ther; 2011 Oct; 11(5):382-98. PubMed ID: 21787295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early steps of retrovirus replicative cycle.
    Nisole S; Saïb A
    Retrovirology; 2004 May; 1():9. PubMed ID: 15169567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A heterologous system for assembly of retroviral gene vectors: intracellular budding in yeast?
    Tolmachov O
    Med Hypotheses; 2006; 67(4):807-9. PubMed ID: 16759811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways.
    Goff SP
    J Gene Med; 2001; 3(6):517-28. PubMed ID: 11778899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudotype-independent nonspecific uptake of gammaretroviral and lentiviral particles in human cells.
    Voelkel C; Galla M; Dannhauser PN; Maetzig T; Sodeik B; Schambach A; Baum C
    Hum Gene Ther; 2012 Mar; 23(3):274-86. PubMed ID: 22010882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication-competent vectors and empty virus-like particles: new retroviral vector designs for cancer gene therapy or vaccines.
    Dalba C; Bellier B; Kasahara N; Klatzmann D
    Mol Ther; 2007 Mar; 15(3):457-66. PubMed ID: 17245356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA is a structural element in retrovirus particles.
    Muriaux D; Mirro J; Harvin D; Rein A
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5246-51. PubMed ID: 11320254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering the impact of parameters influencing transgene expression kinetics after repeated cell transduction with integration-deficient retroviral vectors.
    Schott JW; Jaeschke NM; Hoffmann D; Maetzig T; Ballmaier M; Godinho T; Cathomen T; Schambach A
    Cytometry A; 2015 May; 87(5):405-18. PubMed ID: 25728583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein transduction from retroviral Gag precursors.
    Voelkel C; Galla M; Maetzig T; Warlich E; Kuehle J; Zychlinski D; Bode J; Cantz T; Schambach A; Baum C
    Proc Natl Acad Sci U S A; 2010 Apr; 107(17):7805-10. PubMed ID: 20385817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.